The FDA has authorised the first autonomous robotic blood draw device. It is the least glamorous AI story of the year, and the most convincing one.

The FDA approves Aletta, a robotic device for autonomous blood draws, addressing phlebotomist shortages while ensuring patient safety.

The FDA has authorised the first autonomous robotic blood draw device. It is the least glamorous AI story of the year, and the most convincing one.